After A 50% Fall Sarepta Therapeutics Stock Now Looks Attractive

Sarepta Therapeutics stock, is a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases. SRPT stock is now at the same level it was on Mar 23, 2020, when broader markets made a bottom due to the spread of Covid-19...